The brand developed specifically for the needs of aesthetic medicine was launched in 2009 and acquired by Sinclair Pharma in 2014.

As a new bio-filler generation, the CE certified ELLANSÉ product range permits individual sustainability of one to four years with the ELLANSÉ S, ELLANSÉ M, ELLANSÉ L and ELLANSÉ E products.

This tailor-made, cost effective option is made possible through the unique, proprietary STAT™ technology in the form of controlled and guidable, complete product degradation entirely at the patient’s wish: The polymer chains alter in length and thereby assure the desired chronological durability and efficacy in each case.

The silky texture allows for optimal injection and results in a soft implant with immediate and long-lasting effect. The microparticles feature optimal biocompatibility because of their smooth surface and round shape.

ELLANSÉ is based on polycaprolactone (PCL), a soft, completely resorbable polymer. PCL has been used with success in medical preparations for decades. It has an excellent safety profile, exactly like the viscous agent carboxymethyl cellulose (CMC), which was used in this formulation. PCL microparticles stimulate the formation of new collagen and lead to a long lasting, stable scaffolding for tissue. Elimination takes place through normal metabolism.

Ideal for contouring, shaping and correcting creases and wrinkles and for volume augmentation.



To the physician finder here.

  • Temple- and eyebrow area
  • Cheekbone area
  • Cheeks
  • Nasolabial folds
  • Lower jaw line
  • Shape of nose
  • Marionette wrinkles
  • Chin contouring
      • Sustainable correction for the entire duration of action with a single injection
      • Various levels of action depending on the patient’s needs
      • Completely resorbable products with predictable, controlled and assessable bioresorption and an outstanding safety profile